Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04611347 · ClinicalTrials.gov registry record · Phase 2
Is Topical CBD Effective in Treating Thumb Joint Arthritis
A Phase 2 study of CBD and Hand Osteoarthritis, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT04611347 is a Phase 2 study of CBD and Hand Osteoarthritis that has completed, run by University of Virginia. The registered enrollment target is 18 participants, below the 65-participant average among 8 other CBD trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04611347, a Phase 2 study of CBD and Hand Osteoarthritis, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
Rationale: CBD is commonly being used as an over-the-counter treatment for arthritis-related pain, however no clinical trial has been performed to establish efficacy. Hypothesis: CBD is more effective than placebo for relieving pain and improving patient-reported outcomes for thumb basal joint arthritis. Study Design: The study design with be a double-blind, randomized controlled trial with crossover. Treatment will be blinded to the subjects and investigators. Patients will be randomly assigned 2 weeks of the CBD or control and then crossover to the other condition for 2 additional weeks. Patients will apply the cream at the thumb base twice daily for 1 hour. Subjects will be advised to observe for physiologic changes, skin changes, or other adverse effects.
Conditions Studied
Interventions
- DRUG CBD
- DRUG Shea Butter
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2020-07-28 |
| Est. Completion | 2022-05-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04611347
The ClinicalTrials.gov registry entry for NCT04611347 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 65-participant average among 8 other CBD trials with a reported enrollment target (72% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with CBD appearing as the primary indexed condition, and to 2 interventions - of which CBD is the first listed.
NCT04611347 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT04611347 about?
NCT04611347 is a clinical study titled "Is Topical CBD Effective in Treating Thumb Joint Arthritis". Rationale: CBD is commonly being used as an over-the-counter treatment for arthritis-related pain, however no clinical trial has been performed to establish efficacy. Hypothesis: CBD is more effective than placebo for relieving pain and improving patient-reported outcomes for thumb basal joint arth...
What is the current status of trial NCT04611347?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2020-07-28. Estimated completion is 2022-05-11.
What conditions does trial NCT04611347 study?
This clinical trial studies the following conditions: CBD, Hand Osteoarthritis.
What interventions are being tested in trial NCT04611347?
The interventions under investigation include: CBD (DRUG), Shea Butter (DRUG).
Who is sponsoring clinical trial NCT04611347?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04611347 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for CBD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
RCT of CBD for Anxiety in Advanced Breast Cancer
ACTIVE NOT RECRUITING · Phase 2
-
Efficacy of Inhaled Cannabis for Acute Migraine Treatment
COMPLETED · Phase 2
-
Effects of Cannabidiol on Stress and Nicotine Withdrawal
RECRUITING · Phase 1
-
CBD-Microglia PET Study
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms
RECRUITING · NA
-
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.